Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04477928 · ClinicalTrials.gov registry record

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

A clinical trial of Type 1 Diabetes and Celiac Disease, sponsored by Sanford Health.

Recruiting
Registry status
33,000
Enrollment target
4
Study locations

NCT04477928 is a study of Type 1 Diabetes and Celiac Disease that is actively recruiting participants, run by Sanford Health. The registered enrollment target is 33,000 participants, above the 639-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (5064% higher). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04477928, a study of Type 1 Diabetes and Celiac Disease, is actively recruiting participants, sponsored by Sanford Health.

RECRUITING
Registry status
33,000 participants
Enrollment target
4
Study locations

Study Summary

In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.

Interventions

  • DIAGNOSTIC_TEST Sera and whole blood sampling
  • DIAGNOSTIC_TEST Differential Gene Expression (DGE)

Study Locations (4)

North Dakota

  • Sanford Bismarck Region Clinics - Bismarck
  • Sanford Fargo Region Clinics - Fargo

Minnesota

  • Sanford Bemidji Region Clinics - Bemidji

South Dakota

  • Sanford Sioux Falls Region Clinics - Sioux Falls

Trial Details

FieldValue
Enrollment Target 33,000 participants
Start Date 2020-07-17
Est. Completion 2031-03

Sponsor

Sanford Health

34 total trials

What the Registry Record Tells You About NCT04477928

The ClinicalTrials.gov registry entry for NCT04477928 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 33,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 639-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (5064% higher). The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Sera and whole blood sampling is the first listed.

NCT04477928 reports 4 study locations spanning 3 distinct geographic areas - top geographies include North Dakota, Minnesota, South Dakota.

Frequently Asked Questions

What is clinical trial NCT04477928 about?

NCT04477928 is a clinical study titled "General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery". In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.

What is the current status of trial NCT04477928?

This trial is currently recruiting. The enrollment target is 33,000 participants. The study started on 2020-07-17. Estimated completion is 2031-03.

What conditions does trial NCT04477928 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Celiac Disease.

What interventions are being tested in trial NCT04477928?

The interventions under investigation include: Sera and whole blood sampling (DIAGNOSTIC_TEST), Differential Gene Expression (DGE) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04477928?

This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04477928 being conducted?

This trial has 4 study locations across Minnesota, North Dakota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.